Cargando…
Analysis of Complex Absorption After Multiple Dosing: Application to the Interaction Between the P-glycoprotein Substrate Talinolol and Rifampicin
PURPOSE: In order to clarify the effect of rifampicin on the bioavailability of the P-glycoprotein substrate talinolol, its absorption kinetics was modeled after multiple-dose oral administration of talinolol in healthy subjects. METHODS: A sum of two inverse Gaussian functions was used to calculate...
Autores principales: | Weiss, Michael, D’Argenio, David Z., Siegmund, Werner |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9780127/ https://www.ncbi.nlm.nih.gov/pubmed/36163409 http://dx.doi.org/10.1007/s11095-022-03397-6 |
Ejemplares similares
-
Low heritability in pharmacokinetics of talinolol: a pharmacogenetic twin study on the heritability of the pharmacokinetics of talinolol, a putative probe drug of MDR1 and other membrane transporters
por: Matthaei, Johannes, et al.
Publicado: (2016) -
Evaluation of Self-Nanoemulsifying Drug Delivery Systems (SNEDDS) for Poorly Water-Soluble Talinolol: Preparation, in vitro and in vivo Assessment
por: Kazi, Mohsin, et al.
Publicado: (2019) -
Is Ciprofloxacin a Substrate of P-glycoprotein?
por: Park, Miki Susanto, et al.
Publicado: (2011) -
Motion and Gender-Typing Features Interact in the Perception of Human Bodies
por: D’Argenio, Giulia, et al.
Publicado: (2020) -
Development of Novel Rifampicin-Derived P-Glycoprotein Activators/Inducers. Synthesis, In Silico Analysis and Application in the RBE4 Cell Model, Using Paraquat as Substrate
por: Vilas-Boas, Vânia, et al.
Publicado: (2013)